Technology Apr 24, 2026 · 1 min read

AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials

Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.”

WI
Wired
by Emily Mullin
AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials
Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.”
WI
Source

This article was originally published by Wired and written by Emily Mullin.

Read original article on Wired
Back to Discover

Reading List